pentazirinocyclodiphosphathiazene has been researched along with Leukemia L 1210 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lamberts, HB; Lelieveld, P; Mulder, NH; van de Grampel, JC; van der Huizen, AA; van der Meer-Kalverkamp, A; Wilting, T | 1 |
| Kitazato, K; Takeda, S; Unemi, N | 1 |
| Kato, T; Ota, K; Takamoto, S | 1 |
3 other study(ies) available for pentazirinocyclodiphosphathiazene and Leukemia L 1210
| Article | Year |
|---|---|
Isomer-dependent cytostatic activity of bis(1-aziridinyl)cyclophosphazenes.
Topics: Animals; Antineoplastic Agents; Aziridines; Azirines; Cell Survival; Isomerism; Leukemia L1210; Leukemia L5178; Male; Mice; Organophosphorus Compounds; Structure-Activity Relationship | 1986 |
Effect of 1,3,3,5,5-pentaziridino-1-thia-2,4,6-triaza-3,5-diphosphorine-1-oxide, a new antitumor agent with inorganic ring, on various experimental tumors.
Topics: Animals; Antineoplastic Agents; Azirines; Cell Line; Cyclophosphamide; Drug Resistance; Leukemia L1210; Leukemia P388; Male; Melanoma; Mice; Neoplasms, Experimental | 1982 |
[Antitumor effect of 1,3,3,5,5-pentaziridino-1-thia-2,4,6-triaza-3,5- diphoshorine-1-oxide].
Topics: Animals; Azirines; Cell Cycle; Cells, Cultured; Flow Cytometry; Humans; Leukemia L1210; Leukemia P388; Leukemia, Experimental; Mice | 1986 |